Parcion Private Wealth LLC Neurocrine Biosciences Inc Transaction History
Parcion Private Wealth LLC
- $1.51 Billion
- Q3 2025
A detailed history of Parcion Private Wealth LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Parcion Private Wealth LLC holds 2,432 shares of NBIX stock, worth $346,924. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,432Holding current value
$346,924% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
663Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.02 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.4 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$794 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$637 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$440 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...